[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.142.219. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
March 21, 2001

Orthostatic Hypotension and Chronic Fatigue Syndrome—Reply

Author Affiliations
 

Stephen J.LurieMD, PhD, Senior EditorIndividualAuthorJody W.ZylkeMD, Contributing EditorIndividualAuthor

JAMA. 2001;285(11):1441-1443. doi:10.1001/jama.285.11.1441

In Reply: We do not think the study method of packaging ground fludrocortisone in a hard gelatin capsule with a methylcellulose filler would have interfered with absorption of the active drug, as Dr Baschetti suspects. In examining the dissolution rates of medications packed with various fillers into hard gelatin capsules, Shah and Moore1 identified a delay in dissolution of the medication only when starch was added as the filler to the capsule. Capsules containing ground tablets and various other fillers had varying (and sometimes faster) rates of dissolution than the unground, unencapsulated tablets themselves.1 Their concerns about bias therefore would not apply to the sort of capsule formulation used in our trial, since the capsules were not packaged with starch. We believe that Baschetti has misinterpreted the results of the study by Shah and Moore.

First Page Preview View Large
First page PDF preview
First page PDF preview
×